Dow Jones

40 794,61

1,45%

DAX

Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
NASDAQ
Allos Therapeutics, Inc. (MM) (ALTH)
Allos Therapeutics, Inc. (MM) (ALTH) Actualités

ALTH

Allos Therapeutics, Inc. (MM) (ALTH)

Allos Therapeutics, Inc. (MM)

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:NASDAQ:ALTH

<< Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
26/10/2009	13h00	Business Wire	Allos Therapeutics to Report Third Quarter 2009 Results on November 3, 2009	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
22/10/2009	12h57	Marketwired	BenchmarkJournal.com Provides Sector & Company Analysis on OMC, PSE, PWR, ALTH, NWSA and ELNK	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
13/10/2009	22h23	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
13/10/2009	22h05	Business Wire	Allos Therapeutics Announces Closing of Public Offering	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
13/10/2009	12h40	Marketwired	ELNK, HERO, ABAT, NTAP, DBRN and ALTH Receives Analytical Coverage from WallStSense.com	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
07/10/2009	23h08	Edgar (US Regulatory)	Prospectus filed pursuant to Rule 424(b)(5) (424B5)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
07/10/2009	12h19	Edgar (US Regulatory)	Free Writing Prospectus - Filing under Securities Act Rules 163/433 (FWP)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
07/10/2009	12h14	Business Wire	Allos Therapeutics Announces Pricing of Public Offering of Common Stock	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
05/10/2009	22h01	Business Wire	Allos Therapeutics Announces Proposed Public Offering of Common Stock	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
05/10/2009	13h00	Business Wire	Allos Therapeutics Announces U.S. Availability of FOLOTYN™ (pralatrexate injection) for Relapsed or Refractory Peripheral T...	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
02/10/2009	23h53	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
01/10/2009	12h36	Marketwired	RothmanResearch.com Stock Review for SCG, CA, NE, MKC, COL and ALTH	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
25/09/2009	13h00	Business Wire	Allos Therapeutics’ FOLOTYN™ First and Only FDA-Approved Therapy for Relapsed or Refractory Peripheral T-cell Lymphoma	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
11/09/2009	22h15	Edgar (US Regulatory)	Amended Statement of Ownership (SC 13G/A)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
03/09/2009	00h09	Business Wire	Allos Therapeutics Announces FDA Advisory Committee Recommends Accelerated Approval of FOLOTYN™ (pralatrexate) for the Trea...	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
02/09/2009	12h00	Edgar (US Regulatory)	Notice of Effectiveness (EFFECT)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
01/09/2009	15h05	Edgar (US Regulatory)	Post-Effective Amendment to Registration Statement (POS AM)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
01/09/2009	14h00	Business Wire	Allos Therapeutics to Hold Post Advisory Committee Conference Call	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
31/08/2009	15h31	PR Newswire (US)	Seven Summits Research Releases Comments on Boeing, Joy Global, Ciena Corporation, TakeTwo Interactive and Allos Therapeutics	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
28/08/2009	19h27	Dow Jones News	FDA Has Several Issues With Allos Data For Folotyn	NASDAQ:ALTH	Allos Therapeutics Inc.
14/08/2009	22h16	Edgar (US Regulatory)	Statement of Ownership (SC 13G)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
10/08/2009	16h25	Business Wire	Allos Therapeutics Announces FDA Advisory Committee to Review Pralatrexate for the Treatment of Patients with Relapsed or Ref...	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
04/08/2009	23h16	Edgar (US Regulatory)	Quarterly Report (10-Q)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
04/08/2009	22h00	Business Wire	Allos Therapeutics Reports Second Quarter 2009 Financial Results	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
23/07/2009	16h06	Business Wire	Allos Therapeutics Launches Peripheral T-Cell Lymphoma Website	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
22/07/2009	14h00	Business Wire	Allos Therapeutics to Report Second Quarter 2009 Results on August 4, 2009	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
20/07/2009	14h04	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (S-8)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
20/07/2009	14h00	Edgar (US Regulatory)	Securities Registration Statement (simplified form) (S-3)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
07/07/2009	14h07	Marketwired	BridgewaterEquity.com Free Fundamental Sector & Market Research on OCR, GGC, NWD, MPW, ALTH and NEXM	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
07/07/2009	14h00	Business Wire	Allos Therapeutics Completes Enrollment in Randomized Phase 2b Trial of Pralatrexate in Patients with Advanced Non-Small Cell...	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)